Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He is currently finishing up a Master’s degree in communications at Georgetown University.

Latest Posts

Dr. Eric Topol to Keynote Wednesday Luncheon at #BIO2015

Eric Topol

This week, we are very excited to announce that Dr. Eric J. Topol, director of the Scripps Translational Science Institute, will be joining us as a luncheon at this year’s BIO International Convention in Philadelphia. Dr. Topol’s keynote address will take place on Wednesday, June 17th from 12:00 – 1:30 pm EDT. Voted the #1 Most Influential Physician Executive in the United States in a poll conducted by Modern Healthcare, Topol is also one of Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

What to Watch: Emperor of All Maladies; Killing Cancer

Annie Cavanagh. Wellcome Images

Cancer is a disease which affects almost 1.7 million people each year in America, and is the fastest growing disease on Earth. Two television shows this week explore the history of the complex illness, as well as recent treatment advances that are providing new hope for many patients. The first is a television adaptation of Siddhartha Mukherjee’s The Emperor of All Maladies: A Biography of Cancer, which won the Pulitzer Prize for Nonfiction. The TV Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Jim Greenwood on the Road: Opening Bell at NASDAQ

Jim Ringing Nasdaq Bell

Jim Greenwood, BIO’s President and CEO, rang the opening bell this morning at the NASDAQ MarketSite in New York. Joining him on the stage were a number of BIO members and affiliates, including NewYorkBIO Executive Director Nathan Tinker, Pennsylvania Bio President Christopher Molineaux, DelawareBio Chairman Christopher Yochim, and BioNJ President Debbie Hart. Several BIO member companies were also represented, including Acorda Therapeutics President and CEO Ron Cohen, who also serves as Vice Chair of BIO’s Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

Innovation Files: CSBI Tax Proposals Attempt to Bridge “Valley of Death”

CSBI-logo

Over at the Innovation Files, Joe Kennedy has posted an excellent summary of a set of tax reform proposals developed by the Coalition of Small Business Innovators (CSBI), of which BIO is a member. The proposals would increase investment and employment at small, research intensive companiesby allowing investors to take advantage of passive losses and research credits generated by the company. They would also allow companies to carry net operating losses forward to future years Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

Voting Opens for Everyday Superhero Contest

BIO-InternationalConvention_Graphic_115x176_v3

Earlier this month, members of the biotech community nominated their best and brightest colleagues who are striving to heal, fuel, and feed the world through groundbreaking innovation. Now it is your turn to vote for your favorite BIO Superhero in each of the three categories: Biotech/Pharma, Patient/Patient Group, and University/Research Institution. One vote per email address, per day will be strictly enforced. The individuals with the most votes in each category will win a complimentary Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,